C12Y 304/23046
Memapsin 2 , i.e. beta-secretase 1 or bace
Official title: Memapsin 2 (3.4.23.46), i.e. beta-secretase 1 or BACE
C12Y304/23046 (Memapsin 2 , i.e. beta-secretase 1 or bace) appears on 13 US grants and 27 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 27
- Assignees
- 23
- Inventors
- 86
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 4 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 2 | 3 |
| 2022 | 0 | 3 |
| 2023 | 2 | 1 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement6 Oct 2026US 12,753,411 B2The Brigham and Women S Hospital, Inc.
- Gene therapy for Alzheimer's disease16 Dec 2025US 12,497,608 B2The Brigham and Women S Hospital, Inc.
- Preparation and use of sugar-targeting nanoparticles for modifying SiRNA6 Aug 2024US 12,053,550 B2Henan University
- APKC inhibitors and methods of treating a neurodegenerative disease or disorder9 Jan 2024US 11,865,125 B2The United States Government as represented by the Department of Veterans Affairs
- Antibodies against BACE1 and use thereof for neural disease immunotherapy5 Sep 2023US 11,746,160 B2Adimab, LLC
- Compositions comprising oligonucleotide and uses thereof17 Sep 2026US 2026/0273092 A1siRNAgen Therapeutics Incorporated
- Animal Model With Rapid Onset Of Alzheimer's Amyloid Beta Plaque Pathology12 Dec 2024US 2024/0408246 A1
- Apkc inhibitors and methods of treating a neurodegenerative disease or disorder7 Mar 2024US 2024/0075047 A1The United States Government as represented by the Department of Veterans Affairs
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement4 May 2023US 2023/0136245 A1Paros Bio, Inc.
- Synthetic alpha-secretase and use thereof8 Dec 2022US 2022/0389400 A1Gwangju Institute of Science and Technology
Most cited
By later US patents
- β-secretase enzyme compositions and methods7US 7,456,007 B1Elan Pharmaceuticals, Inc. · 2008
- Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof6US 7,442,537 B1Elan Pharmaceuticals, Inc. · 2008
- Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use4US 11,008,403 B2Adimab, LLC · 2021
- Ligand screening method using a crystal of beta secretase1US 7,829,303 B1Elan Pharmaceuticals, Inc. · 2010